ArticleMolecular and cellular biology2025

Elevated Type I Interferon Signaling Defines the Proliferative Advantage of ARF and p53 Mutant Tumor Cells.

Alex Mabry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.